Saturday, February 6, 2021
AstraZeneca COVID jab ‘less effective against S Africa variant’ | Coronavirus pandemic News
British drugmaker says its vaccine showed ‘limited efficacy against mild disease’ caused by the South African variant of the coronavirus. The COVID-19 vaccine developed by AstraZeneca and the University of Oxford appeared to offer only limited protection against mild disease caused by the South African variant of the coronavirus, a spokesman for the British drugmaker has said. The statement on
Subscribe to:
Post Comments (Atom)
Popular Posts
-
Threat actors are exploiting ProxyLogon and ProxyShell exploits in unpatched Microsoft Exchange Servers as part of an ongoing spam campaign
-
Following the release of iOS 10.3.2 on May 15, Apple has stopped signing iOS 10.3.1, the previous version of iOS that was available to consu...
No comments:
Post a Comment